Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein

Y. N. Chen, L. A. Mickley, A. M. Schwartz, E. M. Acton, J. Hwang, A. T. Fojo

研究成果: 雜誌貢獻文章同行評審

204 引文 斯高帕斯(Scopus)


Development of multidrug resistance due to overexpression of P-glycoprotein (Pgp), a cell membrane drug efflux pump, occurs commonly during in vitro selections with adriamycin (Adr). Pgp-mediated drug resistance can be overcome by the calcium channel blocker verapamil (Vp), which acts as a competitive inhibitor of drug binding and efflux. In order to identify other mechanisms of Adr resistance, we isolated an Adr-resistant subline by selecting the human breast cancer cell line MCF-7 with incremental increases of Adr in the presence of 10 μg/ml verapamil. The resultant MCF-7/Adr Vp subline is 900-fold resistant to Adr, does not overexpress Pgp, and does not exhibit a decrease in Adr accumulation. It exhibits a unique cross-resistance pattern: high cross-resistance to the potent Adr analogue 3'deamino-3'-(3-cyano-4-morpholinyl)doxorubicin, lower cross-resistance to the alkylating agent melphalan, and a sensitivity similar to the parental cell line to vinblastine. The levels of the glutathione and glutathione S-transferase are similar in the parental line and the Adr-resistant subline. Topoisomerase II-DNA complexes measured by the potassium-sodium dodecyl sulfate precipitation method shows a 2-3 fold decrease in the resistant subline. The MCF-7/AdrVp cells overexpress a novel membrane protein with an apparent molecular mass of 95 kDa. Polyclonal antibodies raised against the P-95 protein demonstrate a correlation between the level of expression and Adr resistance. Removal of Adr but not verapmail from the selection media results in a decline in P-95 protein levels that parallels a restoration of sensitivity to Adr. Immunohistochemistry demonstrates localization of the P-95 protein on the cell surface. The demonstration of high levels of the protein in clinical samples obtained from patients refractory to Adr suggests that this protein may play a role in clinical drug resistance.

頁(從 - 到)10073-10080
期刊Journal of Biological Chemistry
出版狀態已發佈 - 1990

ASJC Scopus subject areas

  • 生物化學
  • 分子生物學
  • 細胞生物學


深入研究「Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein」主題。共同形成了獨特的指紋。